Immature megakaryocytes undergo apoptosis in the absence of thrombopoietin

Exp Hematol. 1999 Jan;27(1):131-8. doi: 10.1016/s0301-472x(98)00007-1.

Abstract

We examined withdrawal effects of recombinant mouse Tpo (rm-Tpo) on the apoptosis of mature and immature megakaryocytes in in vitro experiments. Apoptotic megakaryocytes were detected by double staining for acetylcholinesterase and by the TdT-mediated dUTP-biotin nick end labeling (TUNEL) method. When the purified mature megakaryocytes were cultured with or without rm-Tpo, the numbers of viable megakaryocytes, apoptotic megakaryocytes, and megakaryocytes with cytoplasmic processes were not significantly different between the two groups. In contrast, purified immature megakaryocytes underwent apoptosis when rm-Tpo was absent from the culture system. Murine bone marrow cells were cultured with rm-Tpo (50 U/mL) on days 1-7 to generate immature megakaryocytes and subsequently were cultured with different concentrations of rm-Tpo (0-50 U/mL) on days 8-14. The number of viable megakaryocytes was decreased and that of apoptotic megakaryocytes was increased by rm-Tpo in a dose-dependent manner. These results indicated a clear relation between the rm-Tpo level and the apoptosis of immature megakaryocytes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Apoptosis / physiology*
  • Bone Marrow Cells / cytology
  • Cell Count
  • Cell Division / physiology
  • Cell Survival / drug effects
  • Cells, Cultured / drug effects
  • Dose-Response Relationship, Drug
  • Female
  • In Situ Nick-End Labeling
  • Megakaryocytes / cytology*
  • Mice
  • Mice, Inbred Strains
  • Recombinant Proteins
  • Thrombopoietin / pharmacology
  • Thrombopoietin / physiology*

Substances

  • Recombinant Proteins
  • Thrombopoietin